Biblio Discovery — Demo Discovery Service

11 results for "Ismail Essadi"

Showing 1–11 · 1.61 seconds · RSS

  1. Journal Article Full text

    Giant cutaneous pseudolymphoma

    Ismail Essadi; Issam Lalya

    PAMJ Clinical Medicine, Vol. 3 No. 33 · 2020 · French · DOAJ

    A 53-year-old male without significant medical history, presented to our department with a giant tumor mass of the left interscapular region measuring 25 X 13 cm. Physical exam had found a multilobulated mass fixed to the deep plane, with cutaneous infiltration and bluish aspect of the skin…

  2. Journal Article Full text

    Pituitary metastasis of rhabdomyosarcoma: a case report and review of the literature

    Ismail, Essadi; Issam, Lalya; Hamid, Mansouri

    J Med Case Rep · 2014 · English · PubMed Central

    INTRODUCTION: The pituitary gland is an uncommon site for metastases, in particular from rhabdomyosarcoma. Some authors have reported a recent increase in the incidence of metastases at infrequent sites, such as brain or bone, probably due to the expanded treatment options and the resulting…

  3. Journal Article

    Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy

    Hassan Abdelilah Tafenzi; Ismail Essadi; Rhizlane Belbaraka

    Journal of the National Cancer Center, Vol. 6 No. 4 · 2026 · English · DOAJ Scopus

    Despite the PACIFIC trial transforming unresectable stage III non-small cell lung cancer (NSCLC) management, survival gains remain modest and heterogeneous. Current consolidation strategies are fragmented, with redundant “me-too” designs, underuse of dynamic biomarkers, and little consensus on…

  4. Journal Article

    Second-line chemotherapy rechallenge in lung cancer patients: a Moroccan real-world study

    Hassan Abdelilah Tafenzi; Farah Choulli; Ismail Essadi et al.

    Frontiers in Oncology, Vol. 15 · 2025 · English · DOAJ Scopus

    BackgroundImmune checkpoint inhibitors are the go-to therapeutic option for relapsed non-small cell lung cancer (NSCLC) with unidentified oncogenic drivers when first-line platin doublet chemotherapy fails. Meanwhile, few options exist for the treatment of relapsed patients with small cell lung…

  5. Journal Article

    Oxaliplatin and/or gemcitabine vs. FOLFIRINOX in first-line Advanced pancreatic adenocarcinoma: Real-world efficacy and safety data of moroccan patients

    Hassan Abdelilah Tafenzi; Youssef Ait Takniouine; Ismail Essadi et al.

    Cancer Treatment and Research Communications, Vol. 45 · 2025 · English · DOAJ Scopus

    Background: While fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) offers a survival advantage in advanced pancreatic adenocarcinoma (PAC) compared to gemcitabine, gemcitabine-oxaliplatin, and gemcitabine-nab-paclitaxel, the outcome of these regimens in African countries is still…

  6. Journal Article

    A comprehensive analysis of lung cancer status changes over 10 years: results of Moroccan cohort

    Hassan Abdelilah Tafenzi; Youssef AIT Takniouine; Ismail Essadi et al.

    BJC Reports, Vol. 4 No. 1 · 2026 · English · DOAJ

    Abstract Background Assessing long-term trends in lung cancer (LC) patients is challenging, particularly in regions with limited data. We present findings from a real-life Moroccan cohort. Methods This is a retrospective study that included patients diagnosed with LC as a primary malignancy between…

  7. Journal Article

    Radiation-induced chondrosarcoma of the scapula after radiotherapy for lung cancer: a case report and review of the literature

    Abdelfettah Zidane; Adil Arsalane; Mohammed Lahkim et al.

    Journal of Medical Case Reports, Vol. 12 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background Radiotherapy associated with chemotherapy is a well-established treatment modality for locally advanced non-small cell lung cancers. Radiation-induced second malignancies, particularly radiation-induced sarcomas, are rare. Some authors reported a recent increase in the incidence…

  8. Journal Article

    Successful management of retinal metastasis from renal cancer with everolimus in a monophthalmic patient: a case report

    Ismail Essadi; Issam Lalya; Mohamed Kriet et al.

    Journal of Medical Case Reports, Vol. 11 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Background The retina is an uncommon site for metastases, in particular from solid tumors. Some authors have reported a recent increase in the incidence of metastases in infrequent sites, such as brain or bone, probably due to the expanded treatment options and the resulting improved…

  9. Journal Article

    Advanced Treatments in Non-Clear Renal Cell Carcinoma

    Hassan Errihani; Hind M’Rabti; Mohamed Fadl Tazi et al.

    Urology Journal, Vol. 8 No. 1 · 2011 · English · DOAJ Scopus

    PURPOSE: To focus on the use of targeted therapies against the non-clear histologic subtypes of renal cell carcinoma (RCC); papillary I and II, chromophobe, and collecting duct. The unique genetic and molecular profiles of each distinct non-clear kidney cancer subtype will be described, as these…

  10. Journal Article

    Solitary Fibrous Tumor: Case Report of Intrapulmonary Location

    Adil Arsalane; Abdelfetah Zidane; Hicham Fenane et al.

    Case Reports in Oncological Medicine, Vol. 2018 · 2018 · English · DOAJ Scopus

    Solitary fibrous tumors are relatively rare neoplasms that commonly occur in the pleura, especially visceral pleura. However, an intrapulmonary site of this kind of tumors is even rarer. These tumors can be characterized by a heterogeneous evolution and have a benign or malignant behavior. Wide…

  11. Journal Article Full text

    Splenic abscess in cancer chemotherapy

    Ismail, Essadi; El Barni, Rachid; Lahkim, Mohamed et al.

    BMC Res Notes · 2015 · English · PubMed Central

    BACKGROUND: Splenic abcess is an uncommon complication for cancer treatment. It occurs more frequently in immunocompromised patients. They are characterized by high mortality. The classic triad (fever, pain of the left hypochondrium, and sensitive mass left) is only present in one-third of cases…